Cardiogenic shock and nutrition: safe? by Thibault, Ronan et al.
Ronan Thibault
Claude Pichard
Jan Wernerman
Karim Bendjelid
Cardiogenic shock and nutrition: safe?
Received: 18 May 2010
Accepted: 9 September 2010
Published online: 18 November 2010
 Copyright jointly held by Springer and ESICM 2010
R. Thibault  C. Pichard
Nutrition Unit, Geneva University Hospital,
Geneva, Switzerland
R. Thibault
Service d’He´pato-gastro-ente´rologie et Assistance Nutritionnelle,
UMR 1280 Physiologie des Adaptations Nutritionnelles, INRA,
Universite´ de Nantes, CRNH Nantes, Institut des Maladies de
l’Appareil Digestif, CHU Nantes, 44093 Nantes, France
J. Wernerman
Department of Anesthesiology and Intensive Care Medicine,
Karolinska Institutet, Hospital Huddinge, Karolinska University,
Stockholm, Sweden
K. Bendjelid ())
Service de Soins Intensifs, Hoˆpitaux Universitaires de Gene`ve,
Rue Gabrielle-Perret-Gentil, 4, 1211 Geneva 14, Switzerland
e-mail: karim.bendjelid@unige.ch
Tel.: ?41-22-372
Fax: ?41-22-372
Abstract Cardiogenic shock is a common diagnosis in
patients in the intensive care unit (ICU), and is
characterized by a decreased cardiac output in the
presence of adequate intravascular volume associated
with an inadequate tissue perfusion including a
physiological reduction in the splanchnic territory. It
may occur in isolation as a reflection of cardiac
pathology, or it may be part of a shock syndrome
involving other pathogenic mechanisms. As the use of
enteral nutrition (EN) is associated with an increase in
mesenteric arterial output, EN could be deleterious by
overwhelming the mechanisms of mesenteric adaptation.
Accordingly, EN has been suspected to increase the risk
of mesenteric ischaemia, bacterial translocation and
sepsis in ICU patients with cardiogenic shock.
International guidelines recommend a cautious use of
EN within 72 h following cardiogenic shock. Recent
evidence indicates that mesenteric arterial output may
decrease during parenteral nutrition administration,
suggesting that parenteral nutrition could have a
protective effect on splanchnic organs in ICU patients
with cardiogenic shock. Contrary to former beliefs,
several meta-analyses have shown that parenteral
nutrition is not associated with increased mortality.
Exclusive EN is associated with negative energy
balance and the combination of EN with supplemental
parenteral nutrition during the first days following ICU
admission has been proposed to prevent negative energy
balance. Such a nutritional strategy could also be
beneficial for the mesenteric circulation in cardiogenic
shock, and consequently may improve the clinical
outcome of patients with cardiogenic shock. Clinical
trials are warranted to verify these hypotheses.
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Introduction
Early enteral nutrition (EN) is recommended in patients in
the intensive care unit (ICU). Cardiogenic shock (CS) is a
common pathological state in the ICU and is associated
with a mortality rate of around 50% [1]. CS is clinically
defined as a decrease in cardiac output and evidence of
tissue hypoxia in the presence of an adequate cardiac
preload [2]. The European Society of Cardiology has
retained some criteria that usually define CS (Table 1)
[2]. CS may develop after loss of cardiomyocyte function
(e.g. acute myocardial infarction) or as a part of a shock
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syndrome initiated by sepsis, anaphylaxis, hypervolaemia,
etc. In CS the physiological adaptation secondary to heart
damage and insufficiency leads to a decrease in arterial
flow to the brain, lungs and kidneys, and, of utmost
interest for nutritional management, to the liver and
intestine. Severe digestive complications associated with
a low mesenteric arterial supply, such as mesenteric
ischaemia, bacterial translocation and sepsis, have been
reported in patients with CS on EN [3].
The nutritional strategy in ICU patients with CS
remains controversial. Early exclusive EN at a low flow
rate (continuous EN at a rate of 20 ml/h) has been pro-
posed to reduce the risk of severe intestinal
complications, but is associated with negative energy
balance and its related complications [4, 5]. Although
parenteral nutrition (PN) may be associated with
increased metabolic and infectious complications, the use
of PN alone could reduce mesenteric arterial output, and
its associated risk of mesenteric ischaemia.
This review describes the splanchnic haemodynamic
alterations observed in ICU patients with CS and com-
pares the effects of EN and PN on splanchnic
haemodynamics in ICU patients with CS and in healthy
subjects. It also launches the hypothesis that the combi-
nation of EN and supplemental PN in the first days
following ICU admission, besides preventing a negative
energy balance, may also protect the mesenteric circula-
tion in CS. Therefore, EN with supplemental PN may
improve the clinical outcome of patients with CS (Fig. 1).
Clinical trials are warranted to verify these hypotheses.
Haemodynamic changes in the splanchnic
(mesenteric and hepatic) area during CS
Changes in splanchnic circulation during CS
The main characteristics of splanchnic haemodynamics in
some physiological conditions are summarized in
Table 2. Mesenteric blood flow accounts for 10–15% of
cardiac output under fasting conditions. The gut mucosa
is a tissue particularly sensitive to alterations in perfusion
and oxygen status. During feeding, mesenteric organs
maintain a prominent functional hyperaemia character-
ized by a twofold increase in blood flow and metabolic
activity. Pathophysiological mechanisms of mesenteric
flow regulation are complex and depend on the aetiology
of the shock. When the perfusion pressure is reduced in
the small intestine, the ischaemia and the EN-related
accumulation of local metabolites (pH, adenosine, oxy-
gen tension, etc.) induce a vasodilatation mediated by
myogenic and metabolic responses [6]. Moreover, for a
mesenteric blood flow lower than 15 ml/min/100 g of
tissue, local autoregulation of oxygen consumption is
also driven by an increase in tissue oxygen extraction [6].
Unfortunately, this phenomenon may contribute to liver
hypoxia by decreasing the oxygen content available for
the liver via portal venous inflow as already demonstrated
in an animal study [7].
Experimental animal models
In dogs with CS related to cardiac tamponade, the
physiological peripheral vascular response induced by
catecholamines has been shown to lead to a dramatic
decrease in hepatic and portal blood flow [7]. Indeed, the
intense visceral vasoconstriction leads to a decrease in
visceral blood flow as a consequence of a decline in mean
arterial pressure [7]. Conversely, in a nonresuscitated pig
model of septic shock, a decrease in cardiac output
related to septic cardiomyopathy has been shown to be
associated with mesenteric vasoconstriction and hepatic
vasodilatation with a well-maintained liver capillary
perfusion [8].
ICU patients
In critically ill patients with CS, it is not known whether
‘‘increasing intestinal work’’ through EN could induce
such a low flow state and acute mesenteric ischaemia.
Nevertheless, some studies have investigated the human
mesenteric circulation during CS. Indeed, when systemic
blood flow decreases, blood volume is redistributed to
increase cardiac preload (partly by venoconstriction) and
cardiac output, resulting in decreased peripheral vascular
capacitance [9]. As peripheral vascular capacitance is the
tissue capillary ‘‘afterload’’, venoconstriction with an
increase in venous pressure leads to a decrease in organ
perfusion. In this regard, it has been shown that 45% of
nonsurvivors of CS die with a satisfactory cardiac index
(i.e. [2.2 l/min/m2), and high SvO2, indicating that
optimization of macrohaemodynamic parameters alone
may fail to save the patient [10, 11].
These findings have led to a change in the concept of
CS being only a cardiac problem to being an overall
microcirculatory disease, related to the systemic inflam-
matory response syndrome, and, through the release of
Table 1 Common haemodynamic monitoring picture of CS
according to the 2008 European Society of Cardiology guidelines
[2]
Criteria Threshold defining CS
Heart rate (beats/min) Usually [100
Systolic blood pressure (mmHg) Low, usually \90
Cardiac index (l/min/m2) \2.2
Pulmonary capillary wedge
pressure (mmHg)
[18
Diuresis (ml/kg/h) \0.5
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Fig. 1 Hypothetical scheme
suggesting an impact of EN and
PN on the outcome of CS. CS
induces a decrease in
splanchnic blood flow, leading
to gut hypoperfusion, and in
turn, increasing the risk of
mesenteric ischaemia.
Mesenteric ischaemia is
frequently complicated by
bacterial translocation and
sepsis, increasing energy needs,
and by gastrointestinal (GI)
intolerance, reducing protein-
energy delivery. This results in
a negative protein-energy
balance, increasing morbidity,
mortality, length of stay and
recovery, and costs. EN at low
flow rate and PN, by reducing
mesenteric blood flow, could
prevent gut hypoperfusion and
the risk of mesenteric
ischaemia. Simultaneously, PN,
by preventing GI intolerance,
and EN, by reducing the risk of
bacterial translocation and
sepsis, have a positive effect on
protein-energy balance, by
improving the balance between
energy needs and protein and
calorie delivery. Therefore,
early combination of EN at a
low flow rate and PN could
have a positive impact on the
clinical outcome of CS
Table 2 Main characteristics of the splanchnic circulation. The main arteries (and portal vein) of the splanchnic circulation are listed
with respect to the organs supplied and their blood flow
Main artery Organs supplied Splanchnic blood flow
Coeliac trunk, divided into hepatic,
splenic and stomach coronary arteries
Oesophagus, stomach, proximal
duodenum, liver, gallbladder,
pancreas, spleen
–
Hepatic artery – 25–30% of total hepatic blood supply
(400–500 ml/min)
Splenic and stomach coronary arteries – 3% of cardiac output under
fasting conditions (200 ml/min)
Superior mesenteric artery Distal duodenum, jejunum, ileum,
colon to the spleen flexure 10–15% of cardiac output under
fasting conditions (800 ml/min)Inferior mesenteric artery Descending colon, sigmoid
colon, rectum
Portal vein – 70–75% of total hepatic blood supply
(1,000–1,100 ml/min)/venous
oxygen saturation = 85%
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proinflammatory cytokines and neurohormones, leading
to multiple organ failure (Fig. 2) [12–14]. Measuring
sublingual microcirculation using orthogonal polarization
spectral imaging, De Backer et al. [14] reported a
decreased proportion of functional capillaries in patients
with CS compared to healthy controls. In addition, these
alterations in microcirculatory blood flow of the sublin-
gual mucosa (which has a similar embryological origin
with the digestive mucosa) were correlated with ICU
mortality [14]. As human [15–17] and animal [18] studies
have shown similar severities and time courses of mi-
crocirculatory changes in the sublingual and in the
splanchnic (gut or gastric) areas, the study by De Backer
et al. [14] suggests that human splanchnic microcircula-
tion could be altered during CS in some patients.
Intestinal ischaemia in the course of critical illness
The microvasculature of the villus exhibits a countercur-
rent arrangement of blood flow in the arterioles and
venules. Thus, much of the blood oxygen diffuses out of
the arterioles directly into the adjacent venules without
ever being carried in the blood to the tips of the villi. In this
system, 80% of the oxygen may take this short-circuit route
and therefore not be available for the metabolic exchanges
in the gut mucosa. Under normal conditions, this oxygen
shunting is not detrimental to the villi. In contrast, it
becomes deleterious under low-flow conditions since
blood arrival at the gut mucosa becomes greatly reduced.
During CS, the low cardiac output induces hypotension
through an increased total systemic vascular resistance and
the action of the renin angiotensin system. Of this
response, which aims to maintain central arterial blood
pressure, 40% is mediated through mesenteric vascular
vasoconstriction [6]. The latter is the primary mechanism
underlying mesenteric ischaemia following CS.
Early identification of mesenteric ischaemia is of great
importance, since the gastrointestinal tract is identified as
the ‘‘motor’’ of multiple organ failure [17] (Fig. 2).
Indeed, the most severe complications of mesenteric
ischaemia, i.e. mesenteric infarction and peritonitis, fre-
quently occur with the development of septic shock and
multiple organ failure. In the setting of the ICU, intense
abdominal pain, which is often a symptom of mesenteric
ischaemia, is less reliable, since patients are deeply
sedated and are frequently receiving high doses of anal-
gesics. Intestinal malabsorption is also present but it is a
nonspecific and late sign of intestinal ischaemia. There-
fore, it is necessary to have other criteria to detect the
early onset of mesenteric ischaemia in critically ill
patients with CS. Several methods for the measurement of
regional splanchnic blood flow have been evaluated in the
ICU setting, but their validation is questionable since no
gold standard exists. These methods include:
1. Fick principle using the measurement of indocyanine
green clearance which depends on liver dye extraction
(altered in hepatic dysfunction).
2. Monitoring the oxygen saturation of subhepatic veins.
3. Gastric tonometry, as microcirculation in the gastric
mucosa is compromised early during blood flow
redistribution [19, 20]. (This technique coupled with
measurement of intramucosal pH in critically ill
patients could be related to erroneous measurements
if hydrogen ions are secreted by parietal cells [22]).
4. Duplex ultrasound [23, 24].
5. Sublingual capnometry.
6. Measuring sublingual microcirculation using orthogo-
nal polarization spectral imaging which is a promising
method for monitoring the gut microcirculation [14–
18]. However, in the absence of clinical trials, its
routine use cannot be recommended in ICU patients.
Fig. 2 Gut ischaemia as a motor of multiple organ failure (MOF)
in ICU patients. Cardiogenic shock induces a decrease in splanch-
nic blood flow, leading to gut hypoxia and the risk of mesenteric
ischaemia. Gut hypoxia increases intestinal permeability and
bacterial translocation. The bacterial endotoxins are responsible
for a major gut immune response, inducing the secretion of
proinflammatory cytokines, such as tumour necrosis factor a
(TNFa) and interleukins (IL1 and IL6). These cytokines further
exacerbate the inflammatory process in body tissues, leading to the
onset of MOF. MOF aggravates splanchnic hypoxia and leads to the
persistence of cardiogenic shock
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Undoubtedly, future research focusing on more precise
methods of mesenteric arterial flow measurements is
warranted.
Impact of starvation, oral or EN, on mesenteric
arterial output
Healthy subjects
In healthy subjects, oral intake induces physiological
adaptive haemodynamic changes, consisting of an
increase in both cardiac output and mesenteric flow [25,
26] together with an increase in splanchnic oxygen con-
sumption [27]. After a meal, the superior mesenteric
artery (SMA) blood flow increases reaching a value
higher than 40% of total cardiac output [28]. In healthy
subjects, the mesenteric response to oral intake depends
on the energy [29] and on the macronutrient content of the
meal [23, 25, 26, 30]. In one study [25], the increase was
higher after fat administration, and, in another [26], the
increase was higher after protein administration. Con-
versely, the osmolarity of oral intake did not affect
mesenteric blood flow [26]. Therefore, the response to
feeding via healthy gut is associated with an increased
blood flow to the splanchnic circulation and enhanced
gastric acid secretion [31]. Thus, it has been anticipated
that EN alone may modify the haemodynamic adaptive
response to CS. Through the increase in mesenteric
arterial blood flow and the ATP consumption related to
nutrient absorption [24, 32], EN may induce gut hypo-
perfusion and mesenteric ischaemia.
ICU patients
Several studies have shown that the administration of EN
in haemodynamically stable individuals with circulatory
shock is associated with an increase in splanchnic blood
flow and oxygen delivery [32, 33]. However, none of
these studies was performed in ICU patients with CS. In
patients undergoing cardiopulmonary bypass and requir-
ing dobutamine and/or norepinephrine [32] or in
mechanically ventilated patients with severe sepsis [34],
the postpyloric administration of EN solution induces an
increase in splanchnic blood flow related to splanchnic
vasodilatation. This results in an increase in cardiac out-
put and a decrease in systemic vascular resistance [31,
34]. However, conflicting results have been found
regarding the impact of EN on hepatic arterial blood flow.
Increased [34] as well as normal values [32, 35] have
been reported, together with hypoperfusion of the gastric
mucosa [32]. All these parameters returned to within
normal ranges after cessation of EN. In parallel, there was
no change in splanchnic oxygen consumption or in gastric
mucosal energy balance, and an increased cardiac output
was observed even in patients requiring norepinephrine.
Thus, with an increase in mesenteric blood flow, intestinal
perfusion remains adequate during EN in patients with
normal cardiac function.
Recently, using semiquantitative estimates of the
blood flow in the SMA determined by duplex ultraso-
nography, Gatt et al. [24] studied the changes in SMA
blood flow in 14 healthy volunteers and 20 haemody-
namically stable ICU patients, 3 h after the initiation of
EN or PN. Patients fed enterally showed increased post-
prandial SMA blood flow from 7.3 ml/s (range
2.9–12.1 ml/s) to 11.2 ml/s (range 8.2–26.0 ml/s;
P = 0.007), while patients on PN showed decreased
postprandial SMA blood flow from 14.5 ml/s (range
4.8–24.8 ml/s) to 6.1 ml/s (range 2.4–9.2 ml/s;
P = 0.013). The increased splanchnic blood flow induced
by EN may be related to hormonal regulation, since
Parker et al. [29] have shown that there is a positive
correlation between the meal energy content and post-
prandial increases in N-terminal neurotensin and
noradrenaline concentrations. In addition, Brundin and
Wahren [36] have shown that intravenous glucose
administration induces an increased oxygen demand and
blood flow in extra-splanchnic tissue, while splanchnic
energy expenditure and perfusion decrease. It therefore
could be hypothesized that glucose administered paren-
terally shunts blood away from the gut that, in turn,
decreases splanchnic blood flow. From these observa-
tions, possible advantages and disadvantages of EN and
PN in ICU patients with CS are depicted in Table 3.
However, the main question remains: what are the
effects of EN support on splanchnic haemodynamics in
patients with CS? Some clinical reports suggest that early
EN could be associated with gut ischaemia in relation to
alterations in splanchnic blood flow in patients with
severe circulatory failure [37–39]. ICU patients with CS
may be vulnerable to gut haemodynamic alterations
related to EN administration. Indeed, in CS, the heart is
unable to respond to an increase in splanchnic blood flow,
increasing the risk of mesenteric ischaemia.
It has been hypothesized that low flow states in rela-
tion to alterations of splanchnic perfusion may limit the
effectiveness of intestinal nutrient absorption [40]. Berger
et al. [39] analysed paracetamol kinetics in 16 patients
who had undergone cardiac surgery with adequate hae-
modynamic status and 23 patients with haemodynamic
failure, and found no abnormalities in intestinal absorp-
tion in either group. Therefore, haemodynamic failure is
not a contraindication to the use of EN in ICU patients
with CS on the basis that circulatory failure could affect
the intestinal absorptive function.
In summary, nutritional support affects SMA blood
flow in haemodynamically stable ICU patients. However,
it is not possible to draw any conclusions about the
clinical impact of these changes on ICU patients with CS
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since: (1) no study has been performed in this subgroup of
patients; (2) haemodynamic measurements have never
been correlated with clinical events; and (3) it cannot be
excluded that the increase in splanchnic blood flow rela-
ted to EN could be beneficial in patients with CS, by
reinforcing the intestinal epithelial barrier. However,
although data are somewhat conflicting, it can be stated
that haemodynamic response to enteral feeding may or
may not be adequate in critically ill patients with low flow
states, indicating the need for careful monitoring [41].
Clearly, clinical trials are warranted to answer these
questions. The aim of these studies will be to investigate
the effects of nutritional support on splanchnic blood flow
continuously monitored by noninvasive techniques, such
as duplex ultrasonography, in different subgroups of
patients. They should determine whether other intrinsic
factors could be involved and elucidate the mechanisms
underlying the haemodynamic changes in the splanchnic
area in the context of the nutritional support.
Relevance of nutritional support in the management
of critically ill patients with CS
Impact of undernutrition and protein-energy deficits
in patients with CS
Undernutrition is found in around 50% of patients with
severe chronic congestive heart insufficiency [42], and in
9% of patients undergoing cardiac surgery [43]. Cardiac
cachexia and undernutrition are independent predictive
factors of mortality, prolonged length of stay and
increased incidence of postoperative complications in
patients with chronic heart failure [43, 44]. Independent
of the nutritional status, a state of negative energy balance
is also associated with increased morbidity in ICU
patients. In a recent prospective study in 48 critically ill
patients, including 13 patients undergoing cardiac sur-
gery, Villet et al. [5] reported that EN alone led to
insufficient energy and protein coverage 1 week after ICU
admission, and that this energy deficit correlated with
both total and infectious complications. In another study
of 50 critically ill patients, a strong positive relationship
between the cumulated energy debt and the frequency of
complications, including adult respiratory distress syn-
drome, renal failure, need for surgery, and pressure sores,
has been reported [4]. In ICU patients with CS, EN is
frequently insufficient to obtain sufficient optimal energy
delivery [21]. A Swedish study in cardiothoracic ICU
patients has confirmed that it is usually not possible to
meet the entire nutritional requirement by EN [45]. This
observation may be related to the fact that vasoactive
drugs (dopamine, dobutamine and norepinephrine) are
independent risk factors for a high gastric aspirate volume
and digestive intolerance [46]. Moreover, the use of
vasoactive drugs is positively correlated with muscle
catabolism and negatively correlated with enteral energy
intakes [21].
The increased incidence of complications resulting
from undernutrition and energy deficit translates into a
prolonged hospital stay and increased health-care costs
[47–50]. Therefore, it is mandatory to provide ICU
patients, including those with CS, with minimum amounts
of energy and nutrients to improve their clinical outcome
[51].
Choice of nutritional support in patients with CS
Recent evidence-based European and American nutri-
tional guidelines advocate an early initiation of EN
(within 24 or 48 h of admission to the ICU, respectively)
as the preferred route of nutritional support in ICU
patients [42, 52–55]. Early initiation of EN is associated
with a reduced risk of infections, lower ICU mortality,
Table 3 Advantages and disadvantages of EN and PN in ICU patients with CS (advantages of one route are often considered as
disadvantages of the other)
Enteral nutrition Parenteral nutrition
Advantages Disadvantages
Maintenance of intestinal trophicity Gut mucosal atrophy (not proven in humans)
Decreased risk of bacterial translocation and infections Increased risk of bacterial translocation and infections
Better regulation of insulin secretion and glycaemia Hyperglycaemia and insulin resistance
No dysfunction in lipid metabolism Risk of hypertriglyceridaemia
No risk of hepatic dysfunction Risk of hepatic dysfunction
Lower risk of complications with overfeeding More serious consequences of overfeeding
Lower risk of refeeding syndrome Higher risk of refeeding syndrome
Better bile clearance, reduced risk of hydrocholecystis Higher risk of hydrocholecystis
Disadvantages Advantages
Increased SMA and hepatic blood flow Reduced SMA blood flow
Risk of mesenteric ischaemia Decreased risk of mesenteric ischaemia
Risk of gastrointestinal intolerance (vomiting, aspiration, diarrhoea, etc.) No risk of aspiration and of gastrointestinal intolerance
Delayed achievement of the energy target Immediate achievement of the energy target
Frequently associated with negative protein-energy balance Improvement of the protein-energy balance
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lower hospital mortality and shorter length of ICU stay in
mechanically ventilated ICU patients [56–60], and with a
decreased rate of infectious complications, a shorter total
length of hospital stay, and lower overall costs of man-
agement of postsurgical patients [61, 62]. However, EN is
frequently insufficient to cover the energy expenditure
even in the hands of a well-trained and experienced
nutrition team.
Based on the hypothesis that EN alone could be
harmful in ICU patients with CS, the nutritional man-
agement of these patients remains controversial and
essentially based on expert opinion. Indeed, randomized
studies comparing the use of PN and EN and evaluating
the clinical outcome are lacking. As a result, recent ICU
guidelines provide no specific recommendation for
nutritional support in ICU patients with CS, except the
necessity for haemodynamic stability before initiating the
nutritional support [63]. The few clinical studies per-
formed in patients with haemodynamic instability
demonstrate that EN could be well tolerated. In the study
by Berger et al. [39] in 16 ICU patients with adequate
haemodynamic status and 23 patients with severe hae-
modynamic instability following open-heart surgery,
postpyloric or gastric EN initiated at the rate of 20 ml/h
between days 2 and 5 after admission was well tolerated.
Berger et al. [21] have also reported that 70 patients with
haemodynamic failure after cardiopulmonary bypass
could receive EN with a minimum mean daily energy
deficit (-255 ± 370 kcal/day) without experiencing
serious gastrointestinal complications. Moreover, in
patients with the most severe cardiac failure needing the
insertion of an intraaortic balloon pump, the 7-day energy
deficit was lower (270 vs. 1,920 kcal). Thus, EN may be
possible in most patients with severe haemodynamic
failure [21], but usually results in hypocaloric feeding.
The choice of enteral solution does not appear to be
critical for digestive tolerance. Indeed, polymeric, pro-
tein-enriched or not [21, 32], and semi-elemental diets
[21, 34, 39] are both well tolerated at a flow rate of
20–40 ml/h. No randomized controlled study has com-
pared the tolerability of EN in patients with CS according
to the fibre content of the solution. In two studies [32, 34],
the tolerability of EN has been evaluated only after a 2 or
3 h infusion. The putative effects of pharmaconutrients,
such as glutamine, omega 3, short-chain fatty acids,
vitamins E and C, selenium, or combination of them, on
the clinical outcome in ICU patients with CS have only
been discussed in relation to animal models (for review,
see reference [64]). Thus, their use in ICU patients with
CS is not recommended.
In specific situations, such as worsening GI intoler-
ance and ventilatory parameters, mean arterial pressure
below 70 mmHg, and an increase in the doses of pressor
agents, some authors have advised the use of total PN
[64]. However, clinical studies supporting this strategy
are lacking. We think that, in these situations, the
tolerability of low flow-rate EN should be evaluated
before deciding to initiate total PN.
In summary, although no clinical data have demon-
strated harmful effects of EN in patients with CS, a
cautious use of EN is advocated during the first 72 h
following ICU admission. The impact of EN on the
splanchnic circulation may depend on the modalities of
administration, i.e. bolus feeding versus continuous
administration. As a minimal flow rate of 20 ml/h seems
to be well tolerated, we suggest that early EN should be
initiated but should not exceed 250–500 ml/day during
the 72 h following ICU admission. The recommendations
concerning the delivery of EN and PN in ICU patients
with CS are summarized in Table 4.
Combined nutritional support: a new combination
to improve the clinical outcome in patients with CS
EN is frequently associated with protein-energy deficit in
ICU patients, a condition associated with increased mor-
bidity. In ICU patients with CS, EN is expected to be
insufficient to meet energy requirements as a low flow
rate is recommended and the use of vasoactive drugs is
associated with gastrointestinal intolerance [46] and pro-
tein-energy deficit [21]. A recent observational study in
1,209 ICU patients demonstrated that early EN or PN,
achieving the energy target in the three first days of the
ICU stay is associated with a decrease in morbidity and
mortality [65]. Thus, supplemental PN together with
insufficient EN could optimize nutritional therapy by
preventing the onset of early energy deficiency. In the
study by Villet et al. [5], the patients receiving combined
EN and PN achieved a higher mean calorie intake
(2,160 kcal/day) than did patients receiving EN alone
(1,365 kcal/day; P \ 0.0001). Other studies have dem-
onstrated that PN could allow a higher proportion of the
energy needs to be met than EN [66, 67]. Recently, we
presented the preliminary results of a prospective, con-
trolled, randomized study [68] which was initiated to
investigate if the delivery of 100% of the energy target in
ICU patients from day 4 by EN and supplemental PN
could optimize their clinical outcome (http://www.
clinicaltrials.gov, study protocol #NCT00802503). We
showed that the mean energy delivery from day 4 to day 8
was higher with EN and supplemental PN than with EN
alone (98.0 ± 19.0% vs. 80.0 ± 31.7%, P \ 0,001) [68].
Therefore, the combination of EN and PN could be an
efficient way to increase mean calorie intake in ICU
patients and to match energy requirements with delivery.
In a study of 49 mechanically ventilated, malnourished
critically ill patients, the combined nutrition group
experienced an improvement in nutritional status [69].
However, until recently, PN has been restricted in ICU
patients, since it has been suggested that it is associated
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with bacterial translocation from the gut to the blood-
stream. However, the actual observed incidence of
bacterial infections is similar in patients receiving PN and
those receiving EN [70]. Recent meta-analyses have
shown no increased mortality for PN in comparison to EN
[53, 57, 71–74]. The benefit of PN is even higher when
trials comparing early PN with delayed EN ([24 h) are
taken into account [71].
Today, PN can be successfully and safely adminis-
tered providing the nutritional needs are adequately met
by the prescription with the objective of avoiding pro-
tein-energy deficit, overfeeding and hyperglycaemia
[75]. With respect to these conclusions, the recent
European Society for Clinical Nutrition and Metabolism
(ESPEN) guidelines recommend the use of PN in com-
bination with EN when EN does not meet 60% of the
energy target within 72 h following ICU admission [63].
From a pathophysiological point of view, the combina-
tion of EN and PN may represent an appropriate way to
feed ICU patients with CS. A partial EN may contribute
to maintaining the integrity of the intestinal epithelial
barrier, thereby reducing the risks of mesenteric
ischaemia and bacterial translocation. As PN reduces
splanchnic arterial blood flow, it may be protective
against the risk of intestinal ischaemia. Thus, we suggest
supplemental PN to be started within 24 h following
ICU admission, and then further adapted according to
enteral intake. PN should be maintained as long as the
CS is present, together with careful cardiac preload
monitoring. PN should gradually be weaned over time as
EN approaches nutritional goal. Clinical trials are now
necessary to demonstrate whether combined nutritional
support could improve the clinical outcome in ICU
patients with or without CS as compared with EN or PN
alone.
Conclusion
Physiological adaptation to CS leads to a reduction in
splanchnic perfusion. The increase in splanchnic blood
flow needed when EN is given may not be possible during
CS, introducing the risk of splanchnic underperfusion,
intestinal ischaemia and/or vital organ–mesenteric blood
steal. From the few studies available, the use of EN does
not seem to be contraindicated, but must be initiated at a
low flow rate. Total PN is indicated in patients with
severe gastrointestinal intolerance or mesenteric ischae-
mia. Minimal EN would lead to a protein-energy deficit,
in turn associated with a worse clinical outcome. As a
recent meta-analysis suggests that early PN is safe, sup-
plemental PN together with EN could limit nutritional
deficiencies when EN is insufficient to cover energy
requirements during the first days after ICU admission.
Clinical trials are warranted to verify the hypothesis that
Table 4 Recommendations for the management of nutritional support in ICU patients with CS
Enteral nutrition Parenteral nutrition Combination enteral/parenteral
Indications All patients unable to meet their energy
needs by oral intake in the 72 h
following ICU admission (C)
All patients with the indications
for EN but complicated by GI
intolerance or intestinal
ischaemia (C)
All patients whose protein-
energy needs are not met after
48 h of EN
Recommendations Early EN should be initiated in the first
24 h in patients fully resuscitated and/or
stable (C)
Strict glycaemic control should
be obtained to avoid the
deleterious effects of
hyperglycaemia and
overfeeding (C)
The same recommendations as
for EN and PN alone are
applicable
EN should be begun at a low flow rate
(20 ml/h) during the first 48 h to
evaluate GI tolerance (E)
Consider de-escalation of PN
together with an increase in
EN energy delivery (E)
EN should be stopped in hypotensive
patients (mean arterial blood pressure
\60 mmHg) or if the doses
catecholamine agentsa need to be
escalated (E)
Strict monitoring for early signs of
intestinal ischaemia (abdominal
distension, high residual gastric
volumes, hypoactive bowel sounds,
metabolic acidosis) is mandatory (E)
Choice of solution Polymeric (E) ‘All-in-one’ solution (E) See beside
Fibre-free (E) No pharmaconutrients (E)
No pharmaconutrients (E)
The grade of recommendation is indicated in parentheses (from references [52, 55, 63])
a Norepinephrine, phenylephrine, epinephrine, dopamine.
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combined EN and PN could improve clinical outcome in
ICU patients with CS.
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